Stryker
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Stryker 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SYK
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.
CEOKevin A. Lobo, MBA
CEOKevin A. Lobo, MBA
Employees53,000
Employees53,000
HeadquartersPortage, Michigan
HeadquartersPortage, Michigan
Founded1941
Founded1941
Employees53,000
Employees53,000
SYK Key Statistics
Market cap150.69B
Market cap150.69B
Price-Earnings ratio50.92
Price-Earnings ratio50.92
Dividend yield0.86%
Dividend yield0.86%
Average volume1.26M
Average volume1.26M
High today$395.23
High today$395.23
Low today$384.33
Low today$384.33
Open price$385.75
Open price$385.75
Volume876.86K
Volume876.86K
52 Week high$406.19
52 Week high$406.19
52 Week low$329.16
52 Week low$329.16
SYK News
Simply Wall St 8h
Should Stryker’s Raised Outlook and Mako Adoption Prompt a Closer Look from Investors?Stryker Corporation recently reported robust second-quarter 2025 results, citing strong growth in its orthopaedics segment and increasing adoption of the Mako r...
Simply Wall St 1d
Are Stryker Shares Fully Priced After Strong Device Sales and Recent FDA Approvals?If you are trying to decide what to do with Stryker stock right now, you are not alone. The company’s shares have had a busy year, climbing more than 10% over t...
TipRanks 2d
Stryker’s Top Executive Makes a Major Stock Sale!New insider activity at Stryker ( (SYK) ) has taken place on August 21, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...
Analyst ratings
75%
of 32 ratingsBuy
75%
Hold
21.9%
Sell
3.1%
More SYK News
TipRanks 2d
Stryker’s Strong Market Position and Strategic Growth Drive Buy RatingBTIG analyst Ryan Zimmerman reiterated a Buy rating on Stryker yesterday and set a price target of $407.00. Elevate Your Investing Strategy: Take advantage of T...
People also own
Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.